Literature DB >> 22510335

Markers of vulnerability to obsessive-compulsive disorder in an ultra-high risk sample of patients who developed psychosis.

Leonardo F Fontenelle1, Ashleigh Lin, Christos Pantelis, Stephen J Wood, Barnaby Nelson, Alison R Yung.   

Abstract

AIMS: The study aims to identify markers of vulnerability to obsessive-compulsive disorder (OCD) in an ultra-high risk sample of patients who developed psychosis.
METHODS: Three hundred and eleven patients at ultra-high risk for psychosis were examined at baseline and after a mean of 7.4 years follow-up. Patients who developed psychosis with OCD (PSY + OCD; n = 13) and psychosis without OCD (PSY - OCD; n = 45) were compared in terms of socio-demographic and clinical features.
RESULTS: PSY + OCD patients displayed greater severity of depression before and after conversion to PSY + OCD, and increased rates of depressive disorders before exhibiting PSY + OCD. However, they only displayed greater severity of anxiety and increased rates of non-OCD anxiety disorders after psychosis. Further, PSY + OCD patients were more likely to report a positive family history for anxiety disorders than PSY - OCD.
CONCLUSION: Although depression and a family history of anxiety disorder may act as vulnerability markers for OCD in psychosis, the resulting anxiety may be a correlate or a consequence of PSY + OCD.
© 2012 Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22510335     DOI: 10.1111/j.1751-7893.2012.00357.x

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  8 in total

1.  Anxiety in youth at clinical high risk for psychosis.

Authors:  Laina McAusland; Lisa Buchy; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert Heinssen; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel H Mathalon; Jean Addington
Journal:  Early Interv Psychiatry       Date:  2015-10-12       Impact factor: 2.732

2.  Diagnostic progression to schizophrenia in 35,255 patients with obsessive-compulsive disorder: a longitudinal follow-up study.

Authors:  Mu-Hong Chen; Shih-Jen Tsai; Chih-Sung Liang; Chih-Ming Cheng; Tung-Ping Su; Tzeng-Ji Chen; Ya-Mei Bai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-03-24       Impact factor: 5.270

3.  Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors.

Authors:  Frederike Schirmbeck; Mathias Zink
Journal:  Front Pharmacol       Date:  2013-08-09       Impact factor: 5.810

4.  A cross sectional study of impact and clinical risk factors of antipsychotic-induced OCD.

Authors:  Marjan Biria; Fiona-Xiaofei Huang; Yulia Worbe; Naomi A Fineberg; Trevor W Robbins; Emilio Fernandez-Egea
Journal:  Eur Neuropsychopharmacol       Date:  2019-07-11       Impact factor: 4.600

5.  Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network Perspective.

Authors:  Hui Lin Ong; Adela-Maria Isvoranu; Frederike Schirmbeck; Philip McGuire; Lucia Valmaggia; Matthew J Kempton; Mark van der Gaag; Anita Riecher-Rössler; Rodrigo A Bressan; Neus Barrantes-Vidal; Barnaby Nelson; G Paul Amminger; Patrick McGorry; Christos Pantelis; Marie-Odile Krebs; Merete Nordentoft; Birte Glenthøj; Stephan Ruhrmann; Gabriele Sachs; Bart P F Rutten; Jim van Os; Lieuwe de Haan; Denny Borsboom
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

6.  Prevalence and clinical characteristics of patients with obsessive-compulsive disorder in first-episode psychosis.

Authors:  Kristen Hagen; Bjarne Hansen; Inge Joa; Tor Ketil Larsen
Journal:  BMC Psychiatry       Date:  2013-05-30       Impact factor: 3.630

Review 7.  Comorbid Obsessive-Compulsive Symptoms in Schizophrenia: Insight into Pathomechanisms Facilitates Treatment.

Authors:  Mathias Zink
Journal:  Adv Med       Date:  2014-06-11

Review 8.  Prediction and prevention of the first psychotic episode: new directions and opportunities.

Authors:  Sara Piras; Gianluca Casu; Maria Antonietta Casu; Alessandro Orrù; Stefania Ruiu; Antonio Pilleri; Gabriella Manca; Giorgio Marchese
Journal:  Ther Clin Risk Manag       Date:  2014-03-28       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.